Skip to main content Accessibility help
×
Hostname: page-component-7b7567c8c-fvjsw Total loading time: 0 Render date: 2026-11-16T08:48:28.323Z Has data issue: false hasContentIssue false

15 - Olfaction in Parkinsonian Syndromes

from Section III - Assessment and Disorders of Olfaction

Published online by Cambridge University Press:  17 August 2009

Warrick J. Brewer
Affiliation:
Mental Health Research Institute of Victoria, Melbourne
David Castle
Affiliation:
University of Melbourne
Christos Pantelis
Affiliation:
University of Melbourne
Get access

Summary

Introduction

Interest in the smell dysfunction of patients with extrapyramidal disorder has increased in recent years with the recognition that most patients with Idiopathic Parkinson's Disease (IPD) are hyposmic and the possibility that olfactory disorder might be an initial event preceding the classical signs of the disease. This has been aided by 18F-dopa positron emission spectroscopy (PET) scan and latterly by the less expensive dopamine transporter scan (DATScan) technique, both of which image cerebral dopamine distribution and raise the possibility of presymptomatic diagnosis. Thus, olfactory disorder can act as a biomarker of a pending disease and may afford the possibility of neuroprotective therapy.

Olfactory testing

Most clinicians do not enquire about olfaction let alone perform any tests of it. At least one-third of the subjects with hyposmia are unaware of their defect (Hawkes et al., 1997) and others complain of loss of taste instead: thus, it is insufficient simply to ask a patient about their sense of smell. Local nasal disease has to be excluded by clinical examination, endoscopy and ideally computed tomography/magnetic resonance imaging (CT/MRI), but a useful clue is that when anosmia is intermittent, the problem is probably conductive i.e. air cannot reach the olfactory neurons in the nose. Conversely, continual anosmia is characteristic of sensorineural loss.

Age has a profound effect on smell function and our recent analysis of smell identification score (Hawkes et al., 2005) showed that ageing effects start at 36 years (Figure 15.1).

Information

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Book purchase

Temporarily unavailable

Save book to Kindle

To save this book to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×